This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2018-03-26 Rx Conf Call"

From HL7Wiki
Jump to navigation Jump to search
 
Line 27: Line 27:
 
* John Hatem
 
* John Hatem
 
* Christof Gessner
 
* Christof Gessner
 +
* Jean Duteau
 +
* Stephen Chu
  
 
=Agenda Items and notes=
 
=Agenda Items and notes=
 
== US Meds - PDMP Mapping==
 
== US Meds - PDMP Mapping==
*  
+
* [https://hl7.github.io/FHIR-ONC-Meds/]
 +
* added banners for those sections of the material that is open for ballot
 +
* New tab has been added for PDMP
 +
**Brett will send out a link with updated material by end of day on Wednesday - Pharmacy WG will comment
 +
** rename "Request" column to PDMP data attribute
 +
** suggest more clarifying information on the scope and context
 +
** Motion to approve this content going to ballot pending one final review of content by Wednesday end of day - Melva/John - 6/0/0 - CARRIED
  
 
==FHIR==
 
==FHIR==
Line 107: Line 115:
 
* March 12, 2018:
 
* March 12, 2018:
 
* March 19, 2018: no discussion
 
* March 19, 2018: no discussion
* March 26, 2018:  
+
* March 26, 2018: no discussion
  
 
==MedicationKnowledge Resource==
 
==MedicationKnowledge Resource==
Line 115: Line 123:
 
* March 12, 2018: FMG wants to see the PSS once co-sponsors have been approved
 
* March 12, 2018: FMG wants to see the PSS once co-sponsors have been approved
 
* March 19, 2018: Melva will see if she can publish a local version for review
 
* March 19, 2018: Melva will see if she can publish a local version for review
* March 26, 2018:
+
* March 26, 2018:no discussion
  
 
==Joint Meeting with IHE Pharmacy and ISO TC215 WG 6==
 
==Joint Meeting with IHE Pharmacy and ISO TC215 WG 6==
Line 130: Line 138:
 
** entryDefinition has a classification element
 
** entryDefinition has a classification element
 
* March 19, 2018: no updates
 
* March 19, 2018: no updates
* March 26, 2018:  
+
* March 26, 2018: no discussion
  
 
==Blood Products/Transfusion/Tissue Update - Project 1370==
 
==Blood Products/Transfusion/Tissue Update - Project 1370==
Line 137: Line 145:
 
* March 12, 2018: no meetings have been held since New Orleans
 
* March 12, 2018: no meetings have been held since New Orleans
 
* March 19, 2018: no updates
 
* March 19, 2018: no updates
* March 26, 2018:
+
* March 26, 2018: no discussion
  
 
== Updates from Workflow==
 
== Updates from Workflow==
Line 143: Line 151:
 
* March 12, 2018: no meeting this week
 
* March 12, 2018: no meeting this week
 
* March 19, 2018: John attended Workflow meeting - he will document updates that are needed related
 
* March 19, 2018: John attended Workflow meeting - he will document updates that are needed related
* March 26, 2018:
+
* March 26, 2018: no discussion
  
 
==AOB==
 
==AOB==
 +
* Unstructured Strength in FHIR
 +
** Christoff to put a tracker in to consider this change with some examples
 
* WGM Agenda
 
* WGM Agenda
 
  Action: start to draft an agenda for the Cologne meeting - Melva
 
  Action: start to draft an agenda for the Cologne meeting - Melva
Line 151: Line 161:
 
==Drug Interaction PSS ==
 
==Drug Interaction PSS ==
 
** Project meetings will be held Wednesday at 9am Pacific
 
** Project meetings will be held Wednesday at 9am Pacific
* March 26, 2018:
+
* March 26, 2018: no discussion
  
 
==Next meeting==
 
==Next meeting==
 
* April 2, 2018:
 
* April 2, 2018:

Latest revision as of 23:00, 26 March 2018

Attendees

  • Scott Robertson (Chair)
  • Melva Peters (Scribe)
  • Brett Marquard
  • John Hatem
  • Christof Gessner
  • Jean Duteau
  • Stephen Chu

Agenda Items and notes

US Meds - PDMP Mapping

  • [1]
  • added banners for those sections of the material that is open for ballot
  • New tab has been added for PDMP
    • Brett will send out a link with updated material by end of day on Wednesday - Pharmacy WG will comment
    • rename "Request" column to PDMP data attribute
    • suggest more clarifying information on the scope and context
    • Motion to approve this content going to ballot pending one final review of content by Wednesday end of day - Melva/John - 6/0/0 - CARRIED

FHIR

The following tracker items were resolved:

FHIR Tracker Items

  • 15105 - MedicationStatement - alignment with WorkFlow
    • notTaken was removed
    • need to consider how to reflect what the prescriber thinks should be taken by the patient - is this a medStatement or is this a MedRequest?
    • Lloyd believes should be using a MedRequest with a "plan" status
    • Choices:
      • take MedStatement back to the way it was
      • US Core - embrace List
      • follow Lloyd's suggestion to use MedRequest with "Plan" status
      • use status field to identify if a prescriber believes the patient should be on this med and uses taken element to identify if the patient is following the order and taking the medication - could previous do this before we aligned MedStatement with workflow
    • March 5, 2018: - deferred until March 12, 2018
      • Ask Lloyd to join call - complete - he can't join on March 12. Need to provide an update to him
    • March 12, 2018:
      • Lloyd believes that MedStatement should only be an indicator of whether the patient/provider says they are taking the medication
      • Options:
        • revert back to having "notTaken"(pre workflow harmonization)
        • provider instructions for medication - should use MedicationRequest - with intent element
        • implement List resources to get active medication list - not preferred
        • current resource with "not taken" as a status - not preferred
      • Need to take this conversation more public -
        • Workflow group - Melva to ask Lloyd to add to Workflow agenda
        • Zulip - posting to Zulip
          • add Workflow discussion
  • 14455 - Workflow report - File:Workflow pharmacy issues Jan 2018.xlsx
    • new report has been run
    • MedicationRequest
      • instantiates - currently supported but workflow has changed the pattern
        • John to talk to Lloyd about the changes needed
    • MedicationAdministration -
      • instantiates - currently supported but workflow has changed the pattern
        • John to talk to Lloyd about the changes needed
    • MedicationDispense
      • Performer - we believe we are consistent
        • Melva to reach out to Lloyd and ask if this is an error in the report - email sent to Lloyd - there is an error on the report.
          • new report to be generated
      • statusReason
        • will add to suppressed-workflow-warnings - different name
        • John to followup with workflow about the reference to DetectedIssue - still outstanding
  • 15136 - Change Dosage to support conditional doses
    • Discussion of the requirement - this is related to conditional dose
    • Scott to pull material from NCPDP
    • John to pull V3 material
    • start to gather requirements and look at existing FHIR material including CDS
  • 15589 - Pharmacy missing isModifierReason
    • MedicationRequest.substitution.allowed
      • do not believe that this should be a "isModifier"
      • will discuss on March 12 call when we have implementers on the call
    • Medication.amount
      • do not believe that this should be a "isModifier"
      • will discuss on March 12 call when we have implementers on the call
    • March 19, 2018:
      • discussion of the purpose of the isModifier flag - discussion of whether there should be isModifier used more often than it is
      • medicationRequest.substitution - will use the wording from the current element and elaborate "this is the element that must be understood from the substitution element. In the substitution block - this is the element that must be understood to understand the meaning of the block
      • medication.amount - agree it is a Modifier
        • should only specify the amount when the medication.code doesn't provide this information
        • then this can not be ignored
Action: Jean to talk to Grahame/Lloyd - about the criteria for when is an element flagged as a Modifier

Action Item List

  • March 5, 2018: No action this week
  • March 12, 2018:
  • March 19, 2018: no discussion
  • March 26, 2018: no discussion

MedicationKnowledge Resource

  • Melva and Jean are creating a draft resource in the build. The next step is to review the existing tracker items to see which can be done with the current draft content, which need to have data elements added, and which will remain out of scope.
  • Feb 26, 2018: no discussion
  • March 5, 2018: no discussion
  • March 12, 2018: FMG wants to see the PSS once co-sponsors have been approved
  • March 19, 2018: Melva will see if she can publish a local version for review
  • March 26, 2018:no discussion

Joint Meeting with IHE Pharmacy and ISO TC215 WG 6

  • Feb 26, 2018: no discussion
  • March 5, 2018: no decision
  • March 12, 2018: will decline a joint meeting for Cologne
    • will commit to provide an update to IHE Pharmacy and ISO as a power point, but can not do a F2F meeting at this time.
  • March 19, 2018: Looks like there will be a joint meeting on Friday, May 18th
  • March 26, 2018: Scott sent possible agenda topics

Catalogue Project

  • March 5: last weeks meeting addressed open issues related to getting the Entry Definition resource cleaned up. There were no Pharmacy specific issues.
  • March 12, 2018: there was a meeting - cleaning up material to get content into the build
    • entryDefinition has a classification element
  • March 19, 2018: no updates
  • March 26, 2018: no discussion

Blood Products/Transfusion/Tissue Update - Project 1370

  • Feb 26, 2018: no discussion
  • March 5, 2018: no updates
  • March 12, 2018: no meetings have been held since New Orleans
  • March 19, 2018: no updates
  • March 26, 2018: no discussion

Updates from Workflow

  • March 5, 2018: no discussion - no Workflow meetings this week
  • March 12, 2018: no meeting this week
  • March 19, 2018: John attended Workflow meeting - he will document updates that are needed related
  • March 26, 2018: no discussion

AOB

  • Unstructured Strength in FHIR
    • Christoff to put a tracker in to consider this change with some examples
  • WGM Agenda
Action: start to draft an agenda for the Cologne meeting - Melva

Drug Interaction PSS

    • Project meetings will be held Wednesday at 9am Pacific
  • March 26, 2018: no discussion

Next meeting

  • April 2, 2018: